Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fluoron GmbH is a specialized German medical technology company that develops and manufactures high-purity biomaterials for vitreoretinal surgery. As a key member of the Geuder Group, the company focuses on the production of perfluorocarbons, silicone oils, and ophthalmic dyes used to treat complex conditions such as retinal detachment and macular holes. Fluoron is distinguished by its proprietary ultra-purification processes, which ensure that its liquid tamponades and staining solutions meet the highest safety standards for intraocular use. Its product portfolio includes widely recognized brands like F-Octane, F-Decaline, and the Brilliant Peel line of surgical dyes. The company's innovations play a critical role in improving surgical visualization and outcomes in delicate eye procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fluron.